Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Majewski

Showing results (111-120 of 128) with videos related to

Pageof 13
Sort By:
Blood|April 13, 2016
The BCL2 selective inhibitor venetoclax induces rapid onset apoptosis of CLL cells in patients via a TP53-independent mechanismMary Ann Anderson, Jing Deng, John F Seymour, et al.
EMBO Reports|February 23, 2017
A non-canonical function of Ezh2 preserves immune homeostasisAjithkumar Vasanthakumar, Dakang Xu, Aaron Tl Lun, et al.
Blood Advances|March 10, 2020
The application of RNA sequencing for the diagnosis and genomic classification of pediatric acute lymphoblastic leukemiaLauren M Brown, Andrew Lonsdale, Andrea Zhu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2015
PIK3CA mutations are associated with decreased benefit to neoadjuvant human epidermal growth factor receptor 2-targeted therapies in breast cancerIan J Majewski, Paolo Nuciforo, Lorenza Mittempergher, et al.
Blood|July 28, 2018
MBD4 guards against methylation damage and germ line deficiency predisposes to clonal hematopoiesis and early-onset AMLMathijs A Sanders, Edward Chew, Christoffer Flensburg, et al.
Cancer Discovery|December 6, 2018
Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients with Progressive Chronic Lymphocytic LeukemiaPiers Blombery, Mary Ann Anderson, Jia-Nan Gong, et al.
Clinical Genetics|July 15, 2017
Whole-exome sequencing is a valuable diagnostic tool for inherited peripheral neuropathies: Outcomes from a cohort of 50 familiesT Hartley, J D Wagner, J Warman-Chardon, et al.
Blood|June 16, 2022
Single-cell multiomics reveal the scale of multilayered adaptations enabling CLL relapse during venetoclax therapyRachel Thijssen, Luyi Tian, Mary Ann Anderson, et al.
Genome Medicine|November 1, 2022
Ganciclovir-induced mutations are present in a diverse spectrum of post-transplant malignanciesHu Fang, Helen H N Yan, Rebecca A Bilardi, et al.
Immunity|September 10, 2013
The pseudokinase MLKL mediates necroptosis via a molecular switch mechanismJames M Murphy, Peter E Czabotar, Joanne M Hildebrand, et al.
Pageof 13

Showing results (111-120 of 128) with videos related to

Sort By:
Pageof 13
Blood|April 13, 2016
The BCL2 selective inhibitor venetoclax induces rapid onset apoptosis of CLL cells in patients via a TP53-independent mechanismMary Ann Anderson, Jing Deng, John F Seymour, et al.
EMBO Reports|February 23, 2017
A non-canonical function of Ezh2 preserves immune homeostasisAjithkumar Vasanthakumar, Dakang Xu, Aaron Tl Lun, et al.
Blood Advances|March 10, 2020
The application of RNA sequencing for the diagnosis and genomic classification of pediatric acute lymphoblastic leukemiaLauren M Brown, Andrew Lonsdale, Andrea Zhu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2015
PIK3CA mutations are associated with decreased benefit to neoadjuvant human epidermal growth factor receptor 2-targeted therapies in breast cancerIan J Majewski, Paolo Nuciforo, Lorenza Mittempergher, et al.
Blood|July 28, 2018
MBD4 guards against methylation damage and germ line deficiency predisposes to clonal hematopoiesis and early-onset AMLMathijs A Sanders, Edward Chew, Christoffer Flensburg, et al.
Cancer Discovery|December 6, 2018
Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients with Progressive Chronic Lymphocytic LeukemiaPiers Blombery, Mary Ann Anderson, Jia-Nan Gong, et al.
Clinical Genetics|July 15, 2017
Whole-exome sequencing is a valuable diagnostic tool for inherited peripheral neuropathies: Outcomes from a cohort of 50 familiesT Hartley, J D Wagner, J Warman-Chardon, et al.
Blood|June 16, 2022
Single-cell multiomics reveal the scale of multilayered adaptations enabling CLL relapse during venetoclax therapyRachel Thijssen, Luyi Tian, Mary Ann Anderson, et al.
Genome Medicine|November 1, 2022
Ganciclovir-induced mutations are present in a diverse spectrum of post-transplant malignanciesHu Fang, Helen H N Yan, Rebecca A Bilardi, et al.
Immunity|September 10, 2013
The pseudokinase MLKL mediates necroptosis via a molecular switch mechanismJames M Murphy, Peter E Czabotar, Joanne M Hildebrand, et al.
Pageof 13